JPH11178A5 - - Google Patents

Info

Publication number
JPH11178A5
JPH11178A5 JP1998024524A JP2452498A JPH11178A5 JP H11178 A5 JPH11178 A5 JP H11178A5 JP 1998024524 A JP1998024524 A JP 1998024524A JP 2452498 A JP2452498 A JP 2452498A JP H11178 A5 JPH11178 A5 JP H11178A5
Authority
JP
Japan
Prior art keywords
sequence
promoter
nucleic acid
acid construct
human endoglin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998024524A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11178A (ja
Filing date
Publication date
Priority claimed from DE19704301A external-priority patent/DE19704301C1/de
Application filed filed Critical
Publication of JPH11178A publication Critical patent/JPH11178A/ja
Publication of JPH11178A5 publication Critical patent/JPH11178A5/ja
Withdrawn legal-status Critical Current

Links

JP10024524A 1997-02-06 1998-02-05 ヒトエンドグリン遺伝子プロモーターおよびその使用 Withdrawn JPH11178A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19704301A DE19704301C1 (de) 1997-02-06 1997-02-06 Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie
DE19704301.1 1997-02-06

Publications (2)

Publication Number Publication Date
JPH11178A JPH11178A (ja) 1999-01-06
JPH11178A5 true JPH11178A5 (fr) 2005-08-04

Family

ID=7819364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10024524A Withdrawn JPH11178A (ja) 1997-02-06 1998-02-05 ヒトエンドグリン遺伝子プロモーターおよびその使用

Country Status (15)

Country Link
US (1) US6103527A (fr)
EP (1) EP0857781A3 (fr)
JP (1) JPH11178A (fr)
KR (1) KR19980071084A (fr)
CN (1) CN1196784C (fr)
AR (1) AR011110A1 (fr)
AU (1) AU736724B2 (fr)
BR (1) BR9800563A (fr)
CA (1) CA2222981A1 (fr)
CZ (1) CZ289227B6 (fr)
DE (1) DE19704301C1 (fr)
HU (1) HUP9800247A3 (fr)
PL (1) PL324688A1 (fr)
RU (1) RU2230115C2 (fr)
TR (1) TR199800168A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19704301C1 (de) * 1997-02-06 1998-03-26 Hoechst Ag Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie
HUP9900956A2 (hu) 1998-04-09 2002-04-29 Aventis Pharma Deutschland Gmbh. Egyláncú, több antigéntkötőhely kialakítására képes molekulák, előállításuk és alkalmazásuk
WO2000060068A1 (fr) 1999-04-02 2000-10-12 Hisamitsu Pharmaceutical Co., Inc. Sequences de bases d'expression genique utilisees a des fins therapeutiques et medicaments utilises en therapie genique
RU2295281C2 (ru) * 2005-04-20 2007-03-20 Федеральное государственное учреждение Научно-исследовательский институт детских инфекций, г.Санкт-Петербург Способ оценки тяжести инфекционного поражения цнс у детей
RU2297848C2 (ru) * 2005-05-11 2007-04-27 Александр Веньяминович Иткес Генно-инженерная конструкция vegf-ибмед (vegf-ibmed)
NZ584848A (en) 2007-09-28 2012-09-28 Intrexon Corp Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
WO2010005850A1 (fr) 2008-07-08 2010-01-14 The J. David Gladstone Institutes Procédés et compositions de modulation de l’angiogenèse
WO2014123749A1 (fr) 2013-01-30 2014-08-14 Board Of Regents Of The University Of Nebraska Compositions et procédés pour le traitement de complications associées au diabète

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466596A (en) * 1992-08-25 1995-11-14 Mount Sinai Hospital Corporation Tissue specific transcriptional regulatory element
GB9506466D0 (en) * 1994-08-26 1995-05-17 Prolifix Ltd Cell cycle regulated repressor and dna element
DE19704301C1 (de) * 1997-02-06 1998-03-26 Hoechst Ag Der Promotor des humanen Endoglingens und seine Verwendung für die Gentherapie

Similar Documents

Publication Publication Date Title
JP2002519061A5 (fr)
JP2003525623A5 (fr)
CA2154023A1 (fr) Virus recombinant infectieux a arn a brin negatif non segmente
JP2001524320A5 (fr)
WO1999038972A8 (fr) Genes humains et produits ii d'expression genique
ATE300613T1 (de) Menschliche, für zyklische nukleotide spezifische phosphodiesterase
JP2002535956A5 (fr)
JP2003520017A5 (fr)
WO2000066739A3 (fr) Antigenes de chlamydia, fragments d'adn correspondants et utilisation de ceux-ci
ATE267246T1 (de) Künstliche chromosomen, die die genetische information für die bildung von rekombinantem rna-virus enthalten
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
JPH11178A5 (fr)
EP1209228A3 (fr) Promoteur sensible au stress environnemental
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
NZ508439A (en) Novel endometriosis-associated gene
WO2000043490A3 (fr) Gene de la rhamnosyl-tansferase et utilisations associees
WO1999028439A3 (fr) Erythrovirus et ses applications
DE69934415D1 (de) Neuartiges collectin
EP1849868A3 (fr) Défensines végétales
WO1999058639A3 (fr) Proteines de structure du virus de la maladie affectant le pancreas des poissons et utilisations de ces dernieres
ATE394494T1 (de) Isolierte polynucleotide mit einem verminderten anteil an 5'cpg3' epigenetischen kontrollmotiven, und verwendungen davon
WO1999046375A3 (fr) Sequences d'acide nucleique humaines issues de tissus tumoraux prostatiques
WO2000018916A3 (fr) Genes humains et produits d'expression genique
JPH10210974A5 (fr)
WO2003031459A3 (fr) Modulation des genes dependants de l'expression stat-1